GR3021801T3 - Felbamate for treating Lennox-Gastaut syndrome - Google Patents

Felbamate for treating Lennox-Gastaut syndrome

Info

Publication number: GR3021801T3
Authority: GR; Greece
Prior art keywords: felbamate; gastaut syndrome; lennox; treating; treating lennox
Prior art date: 1989-09-26

Application number

GR960403192T

Other languages

English (en)

Inventor

Robert Duane Sofia

Original Assignee

Carter Wallace

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-26

Filing date

1996-11-28

Publication date

1997-02-28

1996-11-28 Application filed by Carter Wallace filed Critical Carter Wallace

1997-02-28 Publication of GR3021801T3 publication Critical patent/GR3021801T3/el

Links

WKGXYQFOCVYPAC-UHFFFAOYSA-N felbamate Chemical compound NC(=O)OCC(COC(N)=O)C1=CC=CC=C1 WKGXYQFOCVYPAC-UHFFFAOYSA-N 0.000 title abstract 2
201000006792 Lennox-Gastaut syndrome Diseases 0.000 title 1
229960003472 felbamate Drugs 0.000 title 1
206010010904 Convulsion Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Treating Waste Gases (AREA)
Catalysts (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GR960403192T 1989-09-26 1996-11-28 Felbamate for treating Lennox-Gastaut syndrome GR3021801T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/412,964 US4978680A (en)	1989-09-26	1989-09-26	Method for the prevention and control of epileptic seizure

Publications (1)

Publication Number	Publication Date
GR3021801T3 true GR3021801T3 (en)	1997-02-28

Family

ID=23635221

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960403192T GR3021801T3 (en)	1989-09-26	1996-11-28	Felbamate for treating Lennox-Gastaut syndrome

Country Status (7)

Country	Link
US (1)	US4978680A (el)
EP (1)	EP0491094B1 (el)
AT (1)	ATE142492T1 (el)
DE (1)	DE69028542T2 (el)
DK (1)	DK0491094T3 (el)
ES (1)	ES2094145T3 (el)
GR (1)	GR3021801T3 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5055489A (en) *	1990-05-04	1991-10-08	Carter-Wallace, Inc.	Method for the prevention and control of hypoxic damage resulting from cerebral ischemic events
DE69219039T2 (de) *	1991-09-03	1997-07-24	Carter Wallace	Verwendung von Felbamate zur Herstellung eines Arzneimittels zur Behandlung neuropsychopharmakologischer Störungen
US5290808A (en) *	1992-11-06	1994-03-01	Carter-Wallace, Inc.	Method to control the intake of food
US5462966A (en) *	1993-10-15	1995-10-31	Carter-Wallace Inc.	Methods for the prevention and control of cellular damage resulting from coronary artery occlusion-reperfusion
US5492930A (en) *	1994-04-25	1996-02-20	Schering Corporation	Method and formulation for treating CNS disorders
US5728728A (en) *	1996-04-10	1998-03-17	Kozachuk; Walter E.	Methods of providing neuroprotection
US9415222B2 (en)	1998-08-05	2016-08-16	Cyberonics, Inc.	Monitoring an epilepsy disease state with a supervisory module
US7231254B2 (en)	1998-08-05	2007-06-12	Bioneuronics Corporation	Closed-loop feedback-driven neuromodulation
US7242984B2 (en)	1998-08-05	2007-07-10	Neurovista Corporation	Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7277758B2 (en)	1998-08-05	2007-10-02	Neurovista Corporation	Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US8762065B2 (en)	1998-08-05	2014-06-24	Cyberonics, Inc.	Closed-loop feedback-driven neuromodulation
US9375573B2 (en)	1998-08-05	2016-06-28	Cyberonics, Inc.	Systems and methods for monitoring a patient's neurological disease state
US7324851B1 (en)	1998-08-05	2008-01-29	Neurovista Corporation	Closed-loop feedback-driven neuromodulation
US7209787B2 (en)	1998-08-05	2007-04-24	Bioneuronics Corporation	Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9042988B2 (en)	1998-08-05	2015-05-26	Cyberonics, Inc.	Closed-loop vagus nerve stimulation
US7747325B2 (en)	1998-08-05	2010-06-29	Neurovista Corporation	Systems and methods for monitoring a patient's neurological disease state
US9113801B2 (en)	1998-08-05	2015-08-25	Cyberonics, Inc.	Methods and systems for continuous EEG monitoring
US7403820B2 (en)	1998-08-05	2008-07-22	Neurovista Corporation	Closed-loop feedback-driven neuromodulation
ATE244564T1 (de)	1999-02-09	2003-07-15	Univ Virginia	Felbamat-derivate
NZ525662A (en) *	2000-10-25	2005-06-24	Univ Virginia	Substituted felbamate derived compounds
US20030166648A1 (en) *	2002-11-01	2003-09-04	Macdonald Timothy L	Felbamate derived compounds
EP1888570A4 (en) *	2005-04-21	2010-05-19	Medpointe Healthcare Inc	PROCESS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATE PRODUCTS IN THEIR FORMING
US8868172B2 (en)	2005-12-28	2014-10-21	Cyberonics, Inc.	Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8725243B2 (en)	2005-12-28	2014-05-13	Cyberonics, Inc.	Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US7676263B2 (en)	2006-06-23	2010-03-09	Neurovista Corporation	Minimally invasive system for selecting patient-specific therapy parameters
US8295934B2 (en)	2006-11-14	2012-10-23	Neurovista Corporation	Systems and methods of reducing artifact in neurological stimulation systems
WO2008092119A2 (en)	2007-01-25	2008-07-31	Neurovista Corporation	Systems and methods for identifying a contra-ictal condition in a subject
WO2008092133A2 (en) *	2007-01-25	2008-07-31	Neurovista Corporation	Methods and systems for measuring a subject's susceptibility to a seizure
US8036736B2 (en)	2007-03-21	2011-10-11	Neuro Vista Corporation	Implantable systems and methods for identifying a contra-ictal condition in a subject
US9788744B2 (en)	2007-07-27	2017-10-17	Cyberonics, Inc.	Systems for monitoring brain activity and patient advisory device
US7884227B2 (en) *	2007-10-26	2011-02-08	Navinta Llc	Felbamate with improved bulk density
US9259591B2 (en)	2007-12-28	2016-02-16	Cyberonics, Inc.	Housing for an implantable medical device
US20090171168A1 (en)	2007-12-28	2009-07-02	Leyde Kent W	Systems and Method for Recording Clinical Manifestations of a Seizure
US8849390B2 (en)	2008-12-29	2014-09-30	Cyberonics, Inc.	Processing for multi-channel signals
US8588933B2 (en)	2009-01-09	2013-11-19	Cyberonics, Inc.	Medical lead termination sleeve for implantable medical devices
US8786624B2 (en)	2009-06-02	2014-07-22	Cyberonics, Inc.	Processing for multi-channel signals
US9643019B2 (en)	2010-02-12	2017-05-09	Cyberonics, Inc.	Neurological monitoring and alerts
WO2012032508A1 (en)	2010-09-07	2012-03-15	Taro Pharmaceutical Industries Ltd.	Process for the preparation of 2-phenyl-1,3-propanediol

1989
- 1989-09-26 US US07/412,964 patent/US4978680A/en not_active Expired - Lifetime
1990
- 1990-12-17 DK DK90313735.4T patent/DK0491094T3/da active
- 1990-12-17 ES ES90313735T patent/ES2094145T3/es not_active Expired - Lifetime
- 1990-12-17 AT AT90313735T patent/ATE142492T1/de not_active IP Right Cessation
- 1990-12-17 EP EP90313735A patent/EP0491094B1/en not_active Expired - Lifetime
- 1990-12-17 DE DE69028542T patent/DE69028542T2/de not_active Expired - Lifetime
1996
- 1996-11-28 GR GR960403192T patent/GR3021801T3/el unknown

Also Published As

Publication number	Publication date
DK0491094T3 (da)	1996-11-11
EP0491094A1 (en)	1992-06-24
ATE142492T1 (de)	1996-09-15
US4978680A (en)	1990-12-18
DE69028542T2 (de)	1997-02-06
EP0491094B1 (en)	1996-09-11
DE69028542D1 (de)	1996-10-17
ES2094145T3 (es)	1997-01-16

Publication	Publication Date	Title
DK0491094T3 (da)	1996-11-11	Felbamat til behandling af Lennox-Gastaut-syndromet
DE69007220D1 (de)	1994-04-14	Absorbierendes Material.
AU570389B2 (en)	1988-03-10	Effluent treatment for removal of cyanide, arsenic and antimony
GR3027666T3 (en)	1998-11-30	Treatment of cataract with 15-keto-prostaglandin compounds
ZA938107B (en)	1994-06-13	Apparatus for treatment of solid material
DK0654264T3 (da)	2001-07-30	Anvendelse af venlafaxin eller en aryloxypropanaminforbindelse til fremstilling af et lægemiddel til behandling af urininkontinens
DE3779053D1 (el)	1992-06-17
GR3020902T3 (en)	1996-11-30	Use of 15-keto-prostaglandin compound for improvement of encephalic function
EP0455448A3 (en)	1992-07-08	Treatment of pancreatic disease with 15-keto-prostaglandin compounds
PH31556A (en)	1998-11-03	Method of inhibitin myeloperoxidase activity.
NO904329L (no)	1991-04-10	Fremgangsmaate og katalysator for behandling av gasser sominneholder svovelforbindelser.
ZA921108B (en)	1993-08-14	Method of treating Type 1 diabetes.
ZA921107B (en)	1993-08-16	Method of treating Type I diabetes.
HUT47427A (en)	1989-03-28	Bezafibrat for treating diabetes
HU9700598D0 (en)	1997-05-28	Process for profilacting and treating pancreatitis
EP0630383A4 (en)	1998-04-22	METHODS FOR TREATING DIABETIS.
EP0424156A3 (en)	1992-04-22	Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
NZ247406A (en)	1999-05-28	Treatment of osteoporosis with 1 alpha, 24(r)-dihydroxy-22(e)-dehydro-vitamin d3
GB2100112B (en)	1986-05-08	A physical treatment for influencing biological activity
DK0430035T3 (da)	1996-07-29	Anvendelse af benzothiazepiner til fremstilling af lægemidler til behandling af epileptiske anfald
PT82322A (en)	1986-05-01	Process for preparing cycloalkanecarboxanilides
DE3467166D1 (en)	1987-12-10	Spiro-succinimides for treatment of diabetes complications
US4916140B1 (el)	1992-12-29
AR245225A1 (es)	1993-12-30	Composiciones para el tratamiento de cuero.
GB2159390B (en)	1986-05-21	A physical treatment for influencing biological activity